Holdings Channel
Home Articles Latest Filings All Funds Stocks Being Bought Stocks Being Sold Insider Buying
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
CALC — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree CALC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

CALC — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the CalciMedica Insider Buying occurred are:

Gray Television Insider Buying
Vaxart Insider Buying
Azitra Insider Buying
Volato Group Insider Buying
Summit Financial Group Insider Buying
ProFrac Holding Insider Buying
Safehold Inc (New) Insider Buying
Greenwich LifeSciences Insider Buying
Flowers Foods Insider Buying
Federated Hermes Premier Municipal Income Fund Insider Buying

CalciMedica insider buying image
The table below summarizes the most recent CalciMedica insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why CalciMedica insider buys are important for investors to follow.
DateInsiderPriceAmount
4-2-2024
Insider Buy		 Eric W. Roberts
CHIEF BUSINESS OFFICER		 $3.90
CAGR » 		$15,600.00
4,000 shares
1-23-2024
Insider Buy		 Venture Partners VI LP Sanderling
 $3.70
CAGR » 		$2,515,079.57
679,384 shares
1-23-2024
Insider Buy		 Fred A. Middleton
 $3.70
CAGR » 		$2,515,079.57
679,384 shares
12-11-2023
Insider Buy		 Robert N. Wilson
Director		 $3.30
CAGR » 		$1,669.80
506 shares
11-6-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $3.12
CAGR » 		$7,488.00
2,400 shares
11-7-2023
Insider Buy		 A. Rachel Leheny
Chief Executive Officer		 $3.34
CAGR » 		$6,680.00
2,000 shares
11-3-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $2.82
CAGR » 		$42,094.92
14,949 shares
11-3-2023
Insider Buy		 Sudarshan Hebbar
Chief Medical Officer		 $2.74
CAGR » 		$98,600.40
36,000 shares
11-6-2023
Insider Buy		 A. Rachel Leheny
Chief Executive Officer		 $3.12
CAGR » 		$7,614.75
2,440 shares
11-3-2023
Insider Buy		 A. Rachel Leheny
Chief Executive Officer		 $2.85
CAGR » 		$14,250.00
5,000 shares
11-3-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $2.74
CAGR » 		$24,787.86
9,060 shares
8-29-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $3.02
CAGR » 		$673.46
223 shares
8-22-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $3.26
CAGR » 		$8,022.28
2,464 shares
6-26-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $3.59
CAGR » 		$6,822.20
1,900 shares
6-21-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $4.27
CAGR » 		$10,675.00
2,500 shares
6-8-2023
Insider Buy		 A. Rachel Leheny
Chief Executive Officer		 $5.22
CAGR » 		$5,225.00
1,000 shares
6-8-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $5.20
CAGR » 		$2,522.00
485 shares
6-9-2023
Insider Buy		 Fred A. Middleton
Director and >10% Owner		 $5.20
CAGR » 		$3,712.80
714 shares
6-7-2023
Insider Buy		 A. Rachel Leheny
Chief Executive Officer		 $5.19
CAGR » 		$10,376.50
2,000 shares
6-7-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $5.13
CAGR » 		$24,118.45
4,700 shares
6-7-2023
Insider Buy		 Fred A. Middleton
Director and >10% Owner		 $5.04
CAGR » 		$5,040.40
1,000 shares
6-2-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $4.64
CAGR » 		$17,096.30
3,687 shares
5-16-2023
Insider Buy		 A. Rachel Leheny
Chief Executive Officer		 $2.70
CAGR » 		$2,698.00
1,000 shares
5-30-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $3.86
CAGR » 		$7,723.20
2,000 shares
5-31-2023
Insider Buy		 Eric Bjerkholt
Director		 $4.14
CAGR » 		$1,055.00
255 shares
5-31-2023
Insider Buy		 A. Rachel Leheny
Chief Executive Officer		 $4.21
CAGR » 		$4,210.00
1,000 shares
5-23-2023
Insider Buy		 Eric Bjerkholt
Director		 $3.27
CAGR » 		$1,634.00
500 shares
5-23-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $3.03
CAGR » 		$24,226.00
8,000 shares
5-23-2023
Insider Buy		 A. Rachel Leheny
Chief Executive Officer		 $3.34
CAGR » 		$10,031.70
3,000 shares
5-19-2023
Insider Buy		 Fred A. Middleton
Director and >10% Owner		 $2.85
CAGR » 		$28,500.00
10,000 shares
5-16-2023
Insider Buy		 A. Rachel Leheny
Chief Executive Officer		 $2.69
CAGR » 		$2,690.00
1,000 shares
5-17-2023
Insider Buy		 Eric W. Roberts
Chief Business Officer		 $2.70
CAGR » 		$22,421.00
8,300 shares
5-16-2023
Insider Buy		 Sudarshan Hebbar
Chief Medical Officer		 $2.70
CAGR » 		$26,999.00
10,000 shares
5-18-2023
Insider Buy		 Eric Bjerkholt
Director		 $2.70
CAGR » 		$3,504.00
1,300 shares
8-15-2008
Insider Buy		 Groep NV Ing
Director and >10% Owner		 $2.81
CAGR » 		$351,875.00
125,000 shares
3-7-2005
Insider Buy		 Groep NV Ing
>10% Owner		 $1757711.48
CAGR » 		$463,580,582,940.75
263,741 shares

Also See: Institutional Holders of CALC
Also See: SEC filings

CALC Performance Since Insider Purchase
Below we present the annualized performance delivered by CalciMedica stock since 4-2-2024 (the date of the most recent insider purchase). The performance of the investment from the time CalciMedica insider buying occurred is the ultimate test of whether insiders were right about CALC being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 04/03/2024
End date: 05/09/2024
Start price/share: $4.18
End price/share: $5.65
Dividends collected/share: $0.00
Total return: 35.01%
Annualized Gain: 354.92%
Starting investment: $10,000.00
Ending investment: $13,501.00
Years: 0.10

CalciMedica Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent CalciMedica insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding CALC

CalciMedica Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.